Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation

References

• PlunkettAMarksRA review of the epidemiology of psoriasis vulgaris in the communityAustralas J Dermatol1995392252329838718
   PubMedGoogle Scholar
• SterryWBarkerJBoehnckeWHBiological therapies in the systemic management of psoriasis: International Consensus ConferenceBr J Dermatol2004151 Suppl 6931715265063
   PubMed Web of Science ®Google Scholar
• NaldiLColomboPBenedetti PlacchesiEStudy design and preliminary results from the pilot phase of the Praktis study: self reported diagnoses of selected skin diseases in a representative sample of the Italian populationDermatology2004208384214730235
   PubMed Web of Science ®Google Scholar
• FinlayAYCurrent severe psoriasis and the Rule of TensBr J Dermatol200515286186715888138
   PubMed Web of Science ®Google Scholar
• KirbyBFortuneDGBhushanMThe Salford Psoriasis Index: an holistic measure of psoriasis severityBr J Dermatol200014272873210792223
   PubMed Web of Science ®Google Scholar
• ShikiarRBresnahanBWStoneSPValidity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trialsHealth Qual Life Outcomes200315314613569
   PubMedGoogle Scholar
• RappSRExumMLReboussinDMFeldmanSRFleischerABJrClarkARThe physical, psychological and social impact of psoriasisJ Health Psychol1997252553722013093
   PubMedGoogle Scholar
• Del GiglioMGisondiPGirolomoniGThe need for long-term continuous therapy in moderate to severe chronic plaque psoriasisG Ital Dermatol Venereol2007142269276
   Google Scholar
• GisondiPGirolomoniGSampognaFPrevalence of psoriatic arthritis and joint complaints in large population of Italian patients hospitalized for psoriasisEur J Dermatol20051527928316048759
   PubMed Web of Science ®Google Scholar
• KimballABJacobsonCWeissSThe psychosocial burden of psoriasisAm J Clin Dermatol2005638339216343026
   PubMed Web of Science ®Google Scholar
• ParisierDMBagelJGelfandJMNational Psoriasis Foundation clinical consensus on disease severityArch Dermatol200714323924217310004
   PubMedGoogle Scholar
• NeimannALShinDBWangXPrevalence of cardiovascular risks factors in patients with psoriasisJ Am Acad Dermatol20065582983517052489
   PubMed Web of Science ®Google Scholar
• GisondiPGirolomoniGAggiornamento sui trattamenti biologici della psoriasi. [Update on the biological treatment of psoriasis]G Ital Dermatol Venereol2007142Suppl 1111 Italian
   Google Scholar
• GelfandJMNeimannALShinDBRisk of myocardial infarction in patients with psoriasisJAMA20062961735174117032986
   PubMed Web of Science ®Google Scholar
• MalerbaMGisondiPRadaeliAPsoriasis and risk of myocardial infarctionJAMA200729736136217244829
   PubMed Web of Science ®Google Scholar
• ShapiroJCohenADDavidMThe association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control studyJ Am Acad Dermatol20075662963417157411
   PubMed Web of Science ®Google Scholar
• BoehnckeSThaciDBeschmannHPsoriasis patients show signs of insulin resistanceBr J Dermatol20071571249125117916217
   PubMed Web of Science ®Google Scholar
• ColomboGLAltomareGFPerisKModerate and severe plaque psoriasis: cost-of-illness study in ItalyTher Clin Risk Manag2008455956818728854
   PubMedGoogle Scholar
• BraathenLRCost of caring for hospital-based patients in dermatology in EuropeJ Eur Acad Dermatol Venereol20011529211730032
   PubMed Web of Science ®Google Scholar
• DehkharghaniSBibleJChenJGThe economic burden of skin disease in the United StatesJ Am Acad Dermatol20034859259912664024
   PubMed Web of Science ®Google Scholar
• FeldmanSRHornEJInternational Psoriasis CouncilPsoriasis: improving adherence to topical therapyJ Am Acad Dermatol2008591009101618835062
   PubMed Web of Science ®Google Scholar
• UlffEMarotiMKettis-LindbladASingle application of a fluorescent test cream by healthy volunteers: assessment of treated and neglected body sitesBr J Dermatol200715697497817316365
   PubMed Web of Science ®Google Scholar
• CarrollCLFeldmanSRCamachoFTBalkrishnanRBetter medication adherence results in greater improvement in severity of psoriasisBr J Dermatol200415189569715491434
   PubMed Web of Science ®Google Scholar
• McDonaldHPGargAXHaynesRBInterventions to enhance patient adherence to medication prescriptions: scientific reviewJAMA20022882868287912472329
   PubMed Web of Science ®Google Scholar
• DrummondMFO’BrienBJStoddartGLMethods for the Economic Evaluation of Health Care Programmes3rd edNew York, NYOxford University Press2006
   Google Scholar
• ReichKBewleyAWhat is new in topical therapy for psoriasis?J Eur Acad Dermatol Venereol201125 Suppl 4152021507079
   PubMed Web of Science ®Google Scholar
• Queille-RousselCHoffmannVEnevoldAGanslandtCUse of a psoriasis plaque test in the development of a gel formulation of calcipotriol and betamethasone dipropionate for scalp psoriasisJ Dermatolog Treat2011 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• JonssonBChanging health envìronment: the challenge to demonstrate cost-effectiveness of new compoundsPharmacoeconomics200422 Suppl 451015876007
   PubMed Web of Science ®Google Scholar
• Italian Health Economics AssociationProposta di linee guida per la valutazione economica degli interventi sanitari in Italia. Italian guidelines proposal on how to conduct economic evaluation studies of health programsPharmacoeconomics Italian Research Articles2009118393 Italian
   Google Scholar
• FlemingCGanslandtCGuentherLCalcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory studyEur J Dermatol20102046547120413372
   PubMed Web of Science ®Google Scholar
• KaufmannRBibbyAJBissonnetteRA new calcipotriol/betamethasone dipropionate formulation (Daivobet™) is an effective oncedaily treatment for psoriasis vulgarisDermatology200220538939312444337
   PubMed Web of Science ®Google Scholar
• HolKPatient preference for topical psoriasis formulations Available from: http://www.leo-pharma.se/Files/Billeder/Docs/Hol-EADV.pdfAccessed July 19, 2012
   Google Scholar
• NaldiLChatenaudLCastelliETrattamento della psoriasi con farmaci sistemici in Italia, Psocare, Primo Rapporto2006 [Treatment of psoriasis with systemic drugs in Italy, Psocare, First Report 2006]. Italian. Available from: http://www.agenziafarmaco.gov.it/it/content/rapporto-psocareAccessed July 17, 2012
   Google Scholar
• BergMLirvallMNohlgårdDSvenssonMWictorinÅSwedish clinical experts interviews August 29th and advisory board meetingOctober 26, 2011Data on fileRome, ItalyLEO Pharma2012
   Google Scholar
• Italian Medicines AgencyList of marketed medicines Available from: http://farmaco.agenziafarmaco.it/index.php.ItalianAccessed November 1, 2011
   Google Scholar
• Italian Health Ministry2010 National Tariff NomenclatorRome, ItalyItalian Health Ministry2011 Italian
   Google Scholar
• SimoensSHealth economic assessment: a methodological primerInt J Environ Res Public Health200962950256620049237
   PubMed Web of Science ®Google Scholar
• Data on fileRome, ItalyLEO Pharma2012
   Google Scholar
• ColomboGLDi MatteoSPerisKA cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in ItalyClinicoecon Outcomes Res20091535921935307
   PubMedGoogle Scholar
• StormABenfeldtEAndersenSESerupJA prospective study of patient adherence to topical treatments: 95% of patients underdoseJ Am Acad Dermatol20085997598018817998
   PubMed Web of Science ®Google Scholar
• BorghiCCiceroAFGAdherence and persistence with therapyGiornale Italiano di Farmacoeconomia E Farmaco Utilizzazione20081513 Italian
   Google Scholar
• CasulaMTragniECatapanoALI database amministrativi come fonti di dati per la ricerca farmaco epidemiologica. [The administrative databases as data sources for epidemiological research drug]CARE I20113336 Italian
   Google Scholar
• LangleyRGGuptaAPappKWexlerDØsterdalMLCurčićDCalcipotriol plus betamethasone dipropionate gel compared with tacalcitol ointment and the gel vehicle alone in patients with psoriasis vulgaris: a randomized, controlled clinical trialDermatology2011222214815621293107
   PubMed Web of Science ®Google Scholar
• BottomleyJMAulandMEMoraisJBoydGDouglasWSCosteffectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in ScotlandCurr Med Res Opin20072381887190117610804
   PubMed Web of Science ®Google Scholar
• GeigerJMEfficacy of acitretin in severe psoriasisSkin Therapy Lett2003841812858231
   PubMedGoogle Scholar
• SauratJHStinglGDubertretLCHAMPION Study InvestigatorsEfficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)Br J Dermatol2008158355856618047523
   PubMed Web of Science ®Google Scholar
• SchmittJZhangZWozelGMeurerMKirchWEfficacy and tolerability of biologic and nonbiologic systemic treatments for moderateto- severe psoriasis: meta-analysis of randomized controlled trialsBr J Dermatol2008159351352618627372
   PubMed Web of Science ®Google Scholar
• ReichKBurdenADEatonJNHawkinsNSEfficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trialsBr J Dermatol2012166117918821910698
   PubMed Web of Science ®Google Scholar